Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos de Endocrinología | EligiMed
Ensayos clínicos
694 ensayos encontrados
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of TRC101 in Delaying Chronic Kidney Disease Progression in Subjects With Metabolic Acidosis
INTERVENTIONAL
Inicio: 20 de nov de 2018
ID: NCT03710291
Completado
ClinicalTrials.gov
Hemoglobin A1c and Immediate Postsurgical Complications Diabetes Type 2 (HbA1c)
OBSERVATIONAL
Inicio: 1 de jul de 2011
ID: NCT01403961
Completado
ClinicalTrials.gov
Use of a Flexible Catheter for the Administration of Subcutaneous Insulin in Diabetic Ketoacidosis
INTERVENTIONAL
Inicio: 11 de dic de 2016
ID: NCT03182569
Completado
ClinicalTrials.gov
Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma
OBSERVATIONAL
Inicio: 1 de mar de 2018
ID: NCT06067594
Completado
Fase 3
ClinicalTrials.gov
A Trial Comparing Efficacy and Safety of NN1250 With Sitagliptin in Insulin Naive Subjects With Type 2 Diabetes (BEGIN™ : EARLY)
INTERVENTIONAL
Inicio: 1 de ene de 2010
ID: NCT01046110
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de jul de 2020
ID: NCT04450394
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 5 de abr de 2018
ID: NCT03495102
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Event-driven Phase 3 Study to Investigate Efficacy and Safety of Finerenone on the Reduction of Cardiovascular Morbidity and Mortality in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease in Addition to Standard of Care.
INTERVENTIONAL
Inicio: 17 de sept de 2015
ID: NCT02545049
Completado
Fase 3
ClinicalTrials.gov
Effect of Semaglutide 2.4 mg Once Weekly on Function and Symptoms in Subjects With Obesity-related Heart Failure With Preserved Ejection Fraction
INTERVENTIONAL
Inicio: 16 de mar de 2021
ID: NCT04788511
Retirado
Fase 2
ClinicalTrials.gov
A Phase 2b Double-Blind, Randomized, Placebo-Controlled Study of Bimagrumab and Tirzepatide, Alone or in Combination, to Investigate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
INTERVENTIONAL
Inicio: 23 de may de 2025
ID: NCT06901349
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Parallel-Group, Double-Blind 4-arm Study to Investigate the Effects of Treatment With LY3549492 Tablets Compared With Placebo in an Obese or Overweight Population With Type-2 Diabetes (T2D)
INTERVENTIONAL
Inicio: 19 de jun de 2025
ID: NCT07030868
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Open Label, Randomized Study to Assess the Efficacy and Safety of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have Homologous Recombination Repair Gene Mutations (PROfound)
INTERVENTIONAL
Inicio: 6 de feb de 2017
ID: NCT02987543
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Parallel-Arm, Double-Blinded Study Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Patients With Type 2 Diabetes Mellitus on Sulfonylurea Therapy (AWARD-8: Assessment of Weekly AdministRation of LY2189265 in Diabetes - 8)
INTERVENTIONAL
Inicio: 1 de ene de 2013
ID: NCT01769378
Completado
Fase 3
ClinicalTrials.gov
Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes
INTERVENTIONAL
Inicio: 17 de jun de 2019
ID: NCT03914326
Completado
Fase 3
ClinicalTrials.gov
A Prospective Randomized Open-label 6-Month Head-To-Head Trial to Compare Metabolic Effects of Paliperidone ER and Olanzapine in Subjects With Schizophrenia
INTERVENTIONAL
Inicio: 1 de oct de 2007
ID: NCT00645099
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study of Weight-Reducing Effect and Safety in Obese Patients With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de oct de 2001
ID: NCT00029848
Completado
Fase 2
ClinicalTrials.gov
Standard Training Versus Intensive Training for HIIP Delivery System Usage in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de nov de 2004
ID: NCT00099515
Terminado
ClinicalTrials.gov
Natural History Study of Children With Metachromatic Leukodystrophy
OBSERVATIONAL
Inicio: 2 de nov de 2015
ID: NCT01963650
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose (Rimonabant 20 mg) Multicenter Study of Long-Term Glycemic Control With Rimonabant in Treatment-naïve Patients With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de mar de 2005
ID: NCT00257257
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess the Efficacy, Safety and Tolerability of Aleglitazar Plus Metformin Combination Therapy Compared With Placebo Plus Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy
INTERVENTIONAL
Inicio: 1 de oct de 2012
ID: NCT01691846
Anterior
1
...
20
21
22
...
35
Siguiente
Filtros